Robert E. Hoffman
2013
In 2013, Robert E. Hoffman earned a total compensation of $1.5M as Former Senior Vice President, Finance and Chief Financial Officer at Arena Pharmaceuticals, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,500 |
|---|---|
| Option Awards | $235,374 |
| Salary | $360,000 |
| Stock Awards | $710,400 |
| Other | $16,041 |
| Total | $1,470,315 |
Hoffman received $710.4K in stock awards, accounting for 48% of the total pay in 2013.
Hoffman also received $148.5K in non-equity incentive plan, $235.4K in option awards, $360K in salary and $16K in other compensation.
Rankings
In 2013, Robert E. Hoffman's compensation ranked 5,019th out of 12,286 executives tracked by ExecPay. In other words, Hoffman earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,019 out of 12,286 | 59th |
Division Manufacturing | 1,729 out of 4,612 | 63rd |
Major group Chemicals And Allied Products | 495 out of 1,462 | 66th |
Industry group Drugs | 350 out of 1,156 | 70th |
Industry Pharmaceutical Preparations | 280 out of 890 | 69th |
Source: SEC filing on April 28, 2016.
Hoffman's colleagues
We found five more compensation records of executives who worked with Robert E. Hoffman at Arena Pharmaceuticals in 2013.
2013
Jack Lief
Arena Pharmaceuticals
Chief Executive Officer
2013
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2013
Steven Spector
Arena Pharmaceuticals
General Counsel
2013
William Shanahan
Arena Pharmaceuticals
Chief Medical Officer
2013
Harry Hixson
Arena Pharmaceuticals